Feasibility of Neurapheresis™ Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis

  • Post author:
  • Post category:News
  • Post last modified:January 4, 2023

October 4, 2017 - Duke University Medical Center/Minnetronix Neuro Pseudomonas, Acinetobacter and Klebsiella are three multidrug resistant (MDR) gram-negative pathogens that pose a threat to human health. Patients in hospitals…

Continue ReadingFeasibility of Neurapheresis™ Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis

In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis

  • Post author:
  • Post category:News
  • Post last modified:January 4, 2023

October 4, 2017 - Duke University Medical Center/Minnetronix Neuro Cryptococcal Meningitis is caused by Cryptococcus neoformans and is the most common cause of fungal meningitis in adults. Treatment for Cryptococcal…

Continue ReadingIn Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis